Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M38,182Revenue $M16,671Net Margin (%)14.8Z-Score3.2
Enterprise Value $M43,812EPS $4.6Operating Margin %17.2F-Score6
P/E(ttm))15.5Cash Flow Per Share $5.6Pre-tax Margin (%)15.1Higher ROA y-yY
Price/Book4.810-y EBITDA Growth Rate %10.9Quick Ratio1.1Cash flow > EarningsY
Price/Sales2.35-y EBITDA Growth Rate %5.5Current Ratio1.7Lower Leverage y-yY
Price/Cash Flow11.7y-y EBITDA Growth Rate %3.7ROA % (ttm)9.8Higher Current Ratio y-yN
Dividend Yield %2.9Insider Buy (3m)0ROE % (ttm)29.5Less Shares Outstanding y-yY
Payout Ratio %58.0Shares Outstanding M543ROI % (ttm)15.1Gross Margin Increase y-yN

Gurus Latest Trades with BAX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BAXRichard Pzena 2014-12-31 Buy 1.5%$67.24 - $74.7
($71.71)
$ 70.37-2%New holding3,944,140
BAXBill Nygren 2014-12-31 Sold Out -0.75%$67.24 - $74.7
($71.74)
$ 70.37-2%Sold Out0
BAXJean-Marie Eveillard 2014-12-31 Reduce-0.06%$67.24 - $74.7
($71.71)
$ 70.37-2%Reduce -32.14%676,637
BAXMario Gabelli 2014-12-31 Reduce-0.02%$67.24 - $74.7
($71.71)
$ 70.37-2%Reduce -23.14%172,900
BAXJoel Greenblatt 2014-12-31 Buy $67.24 - $74.7
($71.74)
$ 70.37-2%New holding5,186
BAXRobert Olstein 2014-09-30 Sold Out -0.59%$71.28 - $77
($74.81)
$ 70.37-6%Sold Out0
BAXDavid Dreman 2014-09-30 Buy 0.02%$71.28 - $77
($74.81)
$ 70.37-6%New holding3,397
BAXJean-Marie Eveillard 2014-06-30 Add0.18%$71.98 - $75.45
($73.67)
$ 70.37-5%Add 90872.40%1,000,696
BAXVanguard Health Care Fund 2014-06-30 Sold Out -0.11%$71.98 - $75.45
($73.67)
$ 70.37-5%Sold Out0
BAXJohn Keeley 2014-06-30 Buy 0.05%$71.98 - $75.45
($73.67)
$ 70.37-5%New holding37,150
BAXDavid Dreman 2014-06-30 Sold Out -0.01%$71.98 - $75.45
($73.67)
$ 70.37-5%Sold Out0
BAXVanguard Health Care Fund 2014-03-31 Reduce-0.41%$66.49 - $72.85
($68.75)
$ 70.372%Reduce -77.96%531,100
BAXCharles Brandes 2014-03-31 Buy 0.19%$66.49 - $72.85
($68.75)
$ 70.372%New holding204,560
BAXDavid Dreman 2014-03-31 Buy 0.01%$66.49 - $72.85
($68.77)
$ 70.372%New holding2,453
BAXChris Davis 2014-03-31 Sold Out $66.49 - $72.85
($68.77)
$ 70.372%Sold Out0
BAXJean-Marie Eveillard 2014-03-31 Reduce$66.49 - $72.85
($68.77)
$ 70.372%Reduce -85.53%1,100
BAXJean-Marie Eveillard 2013-12-31 Reduce-0.26%$63.89 - $69.47
($66.75)
$ 70.375%Reduce -99.44%7,600
BAXJames Barrow 2013-12-31 Sold Out -0.22%$63.89 - $69.47
($66.75)
$ 70.375%Sold Out0
BAXVanguard Health Care Fund 2013-12-31 Reduce-0.17%$63.89 - $69.47
($66.75)
$ 70.375%Reduce -24.20%2,410,000
BAXRobert Olstein 2013-12-31 Add0.15%$63.89 - $69.47
($66.75)
$ 70.375%Add 24.19%77,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BAX is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


BAX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
HELLMAN PETER SDirector 2015-02-06Sell4,830$71.320.27view
FORSYTH JOHN DDirector 2014-08-15Sell4,830$74.9-4.53view
Shapazian Carole JDirector 2014-07-25Sell1,645$76.98-7.11view
STALLKAMP THOMAS TDirector 2014-07-24Sell8,300$76.82-6.91view
HANTSON LUDWIGCorporate Vice President 2014-07-09Sell24,693$76-5.91view
STROUCKEN ALBERT P LDirector 2014-05-27Sell3,840$74.41-3.9view
Shapazian Carole JDirector 2014-05-02Sell5,680$75.28-5.01view
STROUCKEN ALBERT P LDirector 2014-04-24Buy696$67.525.91view
STORM KEES JDirector 2014-04-23Sell5,760$72.45-1.3view
Devitt Blake EDirector 2014-04-21Sell4,334$73.12-2.2view

Press Releases about BAX :

Quarterly/Annual Reports about BAX:

News about BAX:

Articles On GuruFocus.com
Live Off Your Monthly Dividend Portfolio Mar 19 2015 
Medtronic Inc. (MDT) Dividend Stock Analysis Feb 25 2015 
To Reinvest or Not Reinvest: That is the Question Feb 19 2015 
Best Stock Pick For Long Term Investors Feb 10 2015 
Richard Pzena's New Buys Feb 09 2015 
Richard Pzena's 5 New Q4 Stock Buys Feb 06 2015 
Expectations, Price, and Fundamentals (Or Congressional Questions Gone Awry) Jan 23 2015 
Pfizer Spreading Its Wings Into A New Domain Of Life Sciences Dec 09 2014 
I think Zimmer Will Outperform S&P 500 Performance Dec 04 2014 
Becton, Dickinson and Co. (BDX) Dividend Stock Analysis Nov 19 2014 


More From Other Websites
Final Glance: Pharmaceuticals companies Apr 23 2015
Final Glance: Pharmaceuticals companies Apr 23 2015
Final Glance: Medical Devices companies Apr 23 2015
Final Glance: Medical Devices companies Apr 23 2015
Baxter International (BAX) Earnings Report: Q1 2015 Conference Call Transcript Apr 23 2015
Midday Glance: Pharmaceuticals companies Apr 23 2015
Midday Glance: Pharmaceuticals companies Apr 23 2015
Midday Glance: Medical Devices companies Apr 23 2015
Midday Glance: Medical Devices companies Apr 23 2015
Early Glance: Pharmaceuticals companies Apr 23 2015
Early Glance: Pharmaceuticals companies Apr 23 2015
Early Glance: Medical Devices companies Apr 23 2015
Early Glance: Medical Devices companies Apr 23 2015
Zacks Rank #5 Additions for Thursday - Tale of the Tape Apr 23 2015
Baxter (BAX) Beat on Q1 Earnings and Revenues - Tale of the Tape Apr 23 2015
Baxter International Inc Earnings Call scheduled for 8:30 am ET today Apr 23 2015
Baxter beats Street 1Q forecasts Apr 23 2015
Baxter beats Street 1Q forecasts Apr 23 2015
Baxter Profit Falls on Currency Hit Apr 23 2015
Baxter Reports First Quarter Financial Results That Exceed Guidance Apr 23 2015

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

Sww
ReplySww - 9 months ago
Bax medical devices revenue ~9b, bio science ~7b
using 3X sales of medical devices company and 4X for drugs company, 27b+28b = 55b market cap,as of June 2014, BAX market cap is 39b, so it can sell for

72 * (1 + 16/39) = 99

72 is current stock price, with an upside of around 35%

so my guess is BAX may be able to sell for around 90 after spin-off.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK